Bank of New York Mellon Corp decreased its position in HCA Healthcare Inc (NYSE:HCA) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,261,060 shares of the company’s stock after selling 36,537 shares during the period. Bank of New York Mellon Corp owned approximately 0.65% of HCA Healthcare worth $198,613,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in HCA. Longview Partners Guernsey LTD boosted its stake in HCA Healthcare by 22.6% in the 3rd quarter. Longview Partners Guernsey LTD now owns 11,135,155 shares of the company’s stock worth $886,247,000 after purchasing an additional 2,053,701 shares in the last quarter. American Century Companies Inc. boosted its stake in HCA Healthcare by 49.5% in the 3rd quarter. American Century Companies Inc. now owns 2,558,216 shares of the company’s stock worth $203,608,000 after purchasing an additional 847,377 shares in the last quarter. Brandes Investment Partners LP boosted its stake in HCA Healthcare by 441.7% in the 3rd quarter. Brandes Investment Partners LP now owns 686,968 shares of the company’s stock worth $66,810,000 after purchasing an additional 560,144 shares in the last quarter. Victory Capital Management Inc. boosted its stake in HCA Healthcare by 16.6% in the 3rd quarter. Victory Capital Management Inc. now owns 2,453,352 shares of the company’s stock worth $195,263,000 after purchasing an additional 349,062 shares in the last quarter. Finally, AustralianSuper Pty Ltd bought a new position in HCA Healthcare in the 3rd quarter worth about $24,410,000. Institutional investors own 74.14% of the company’s stock.
In other HCA Healthcare news, major shareholder Thomas F. Frist, Jr. purchased 28,650 shares of HCA Healthcare stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average price of $101.07 per share, with a total value of $2,895,655.50. Following the transaction, the insider now directly owns 389,855 shares of the company’s stock, valued at $39,402,644.85. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, insider Michael S. Cuffe sold 2,400 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $86.63, for a total transaction of $207,912.00. The disclosure for this sale can be found here. Insiders have sold a total of 482,318 shares of company stock valued at $48,394,005 in the last ninety days. Insiders own 2.90% of the company’s stock.
A number of equities analysts recently issued reports on HCA shares. Credit Suisse Group reiterated an “outperform” rating and issued a $25.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 26th. Robert W. Baird set a $104.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Friday, January 12th. Morgan Stanley cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price target on the stock. in a research note on Wednesday, December 20th. Goldman Sachs Group began coverage on shares of HCA Healthcare in a research note on Wednesday, January 3rd. They issued a “neutral” rating on the stock. Finally, Bank of America cut shares of HCA Healthcare from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $94.00 to $90.00 in a research note on Thursday, January 4th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $104.50.
Shares of HCA Healthcare Inc (HCA) opened at $100.54 on Friday. HCA Healthcare Inc has a 52-week low of $71.18 and a 52-week high of $106.84. The company has a market cap of $35,600.00, a PE ratio of 19.68, a PEG ratio of 1.01 and a beta of 0.48. The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.36 and a current ratio of 1.62.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The firm had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. During the same quarter in the prior year, the firm earned $1.80 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts expect that HCA Healthcare Inc will post 8.71 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be given a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a dividend yield of 1.39%. The ex-dividend date is Wednesday, February 28th.
ILLEGAL ACTIVITY WARNING: This report was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/23/bank-of-new-york-mellon-corp-has-198-61-million-position-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.